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Summary.-The method of measuring changes in the structuredness of cytoplasmic
matrix (SCM) in single cells is described. Data on SCM distributions and fractions
of human lymphocyte populations which respond to stimulations with PHA and
CaBP in healthy donors and patients with malignant disorders are presented.
LYMPHOCYTES from patients with
malignant diseases can be differentiated
from those of healthy donors or donors
with non-malignant disorders on the basis
of changes in the structuredness of cyto-
plasmic matrix (SCM) induced by cancer
basic protein (CaBP), tumour-tissue asso-
ciated antigens and phytohaemagglutinin
(PHA) (Cercek, Cercek and Garrett,
1 974b; Cercek, Cercek and Franklin,
1974a; Cercek and Cercek, 1975a, b).
Changes in the SCM are measured on
cell suspensions with the technique of
fluorescence polarization in a fluorescence
spectrophotometer of high sensitivity
(Cercek, Cercek and Ockey, 1973). These
measurements yield data on average
changes in the SCM over whole cell
populations, and cannot yield estimates
of the percentages of cells which change
their SCM on stimulation. We have,
therefore, extended the technique of
fluorescence polarization to measurements
of changes in the SCM on single cells.
This paper describes the SCM technique
for single cells and presents data on
SCM distributions and fractions of lym-
phocyte populations which respond to
stimulations with CaBP and PHA in
healthy donors and in patients with
malignant disorders.
AIATERIALS AND METHODS
Preparation of lymphocytes.-Human lym-
phocytes were prepared from blood collected
in Searle-LH/10 lithium heparin-containing
vials. Lymphocytes in a pure state (>90%0)
wAere obtained by the Ficoll-Triosil gradient
separation (Harris and Ukaejiofo, 1969).
Details of these procedures were described
before (Cercek et al., 1974b). Lymphocytes
were suspended in TC Medium 199 (Wellcome
Ltd) at a concentration of approximately
6 x 106 cells/ml.
Stimulation of lymphocytes.-Aliquots of
0 5 ml of lymphocyte suspensions were in-
cubated for 30 min at 37°C with either
0 05 ml of a 5 times diluted reagent-grade
PHA (Wellcome Ltd) or 0 05 ml of partly
purified CaBP solution. The concentration
of CaBP was, on the basis of the dose
response curve for the particular batch,
adjusted to give a maximum response with
respect to the number of lymphocytes.
CaBP was a gift from Dr J. P. Dickinson,
Cookridge Hospital, University Department
of Radiotherapy, Leeds.
Preparation of FDA solutions.-Fluo-
rescein diacetate (FDA) is practically in-
soluble in water. Aqueous solutions of
FDA in complete phosphate buffered saline
(PBS) (Paul, 1970) are, therefore, prepared
by sequential dilution of a stock solution
of 25 mg of recrystallized FDA/ml of Analar
grade propanone or butan-2-on (Fluka Fluo-L. CERCEK AND B. CERCEK
rochem Ltd). 0-02 ml of the FDA stock
solution is first injected into 100 ml of
sterile PBS. A slightly milky solution is
obtained. This solution tends to flocculate
and must, therefore, be immediately sub-
diluted by injecting 10 ml of this solution
into 100 ml of sterile PBS, with a
further dilution by injecting 20 ml into
50 ml of sterile PBS. This latter solution
(0-31 ,uM FDA in PBS) is used in SCM
measurements. We have noticed that recent
batches of the organic solvents and FDA
contain impurities which decrease the SCM
of lymphocytes. However, the above se-
quential dilution decreases the impurities
below the threshold level at which they
would start to affect the lymphocytes and
thus abrogate mitogenic or antigenic stimula-
tions.
Measurements of SCM.-The SCM of
lymphocytes was measured with the tech-
nique offluorescence polarization. The tech-
nique is based on the excitation of fluo-
rescein molecules produced by enzymatic
hydrolysis of the non-fluorescing substrate,
fluorescein diacetate (FDA), in the cytoplasm
of living cells with polarized light, and
measurement of the degree of polarization
of the emitted fluorescence. Three drops
of control or of incubated lymphocyte
suspensions (approximately 2 x 105 lympho-
cytes) were put on a pre-cleaned and
fluorescence-free, select microslide (Chance
Propper Ltd). The same volume of a
0-31 ,uM FDA solution in complete PBS
solution was added, mixed with a
sterile hypodermic needle and covered
with a pre-cleaned and fluorescence-free
glass coverslip No. 0 (Chance Propper Ltd).
Under our experimental conditions we did
not find it necessary to seal the cover slip
to prevent loss of liquid by evaporation.
After measuring about 50 cells a new slide
was prepared. For lymphocytes stimulated
with PHA or CaBP the incubation times
of each new slide were approximately 30
min. For each histogram 150 to 200 cells
were measured. The fluorescence polariza-
tion measurements of single cells were
carried out at 25°C with a Zeiss microscope-
fluorometer-Ol equipped with an epi-fluo-
rescence condenser III/RS, an electro-
mechanically operated rotating polarizer
(constructed for us by Zeiss) fitted between
the photometer attachment and the tube
body. To prevent photobiological effects
during measurements on living cells and to
obtain maximum excitation of fluorescein
molecules, an interference filter transmitting
light between 400 nm and 490 nm was
installed in front of the excitation polarizer
transmitting vertically polarized light. The
epi-condensor was equipped with a reflector
filter (cut-off below 500 nm) and a barrier
filter (cut off below 505 nm). In all measure-
ments the Zeiss Planapo 40/1f0 oil objective
and Optovar 2-0 were used. The diameter
of the measuring diaphragm in front of the
photo-multiplier was selected to fit the
size of the lymphocyte image. No correc-
tions for scattered light or background
fluorescence were necessary. The intensities
of the emissions parallel, I1, and perpen-
dicular, I I, to the electric vector of the
plane polarized exciting light beam were
displayed on the digital read-out instrument.
The fluorescence polarization values, P,
were calculated from the relationship:
P = (I, - QI1)/(I1 + QIJ), where Q de-
notes a correction factor for the unequal
transmission of the two components of
polarized light through the optical system.
Under our experimental conditions Q was
1-47. The factor Q was derived from
measurements of the intensities of the
practically non-polarized fluorescence emitted
from a 200 ,uM fluorescein solution in ethanol
recorded with the emission polarizer in
the parallel (i,1) and perpendicular (i J)
position, i.e. Q = iI/i1. The accuracy of
this correction was checked by measuring
the fluorescence polarization values, P,
on a series of 50 ,M fluorescein solutions
in water-glycerol mixtures of varying vis-
cosities at 25TC, first in the Perkin-Elmer
fluorescence spectrophotometer MPF-4 and
then under the microscope-fluorometer. The
fluorescence polarization values, P, in the
ranges of0-150 to 0-280, differed by less than
+2%.
Calculation of fractions of lymphocyte
population responding to PHA and CaBP.-
The minimum proportion (F) of lymphocytes
which must undergo a change of P in order
to convert the control distribution into the
treated distribution can be calculated as
follows:
F 2 (Fs, -Fc, i)Fs >Fc
v
+2- (FC, i - Fs, i)FC >Fs (I)
v
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where Fs, i and Fc, i denote fractions of
lymphocytes per polarization interval of
P-002 and the subscripts: i, the running
interval; s, stimulated lymphocytes and
c, control lymphocytes.
RESULTS
The control SCM values of individual
lymphocytes in populations from 5 healthy
donors and 7 patients with cancer range
from P 0 10 to P 0 30 with mean
values of P ranging from 0-188 to 0-221
(Table I). Examples of distributions of
P values within a population of lympho-
cytes from a healthy donor and a donor
with cancer are shown as histograms in
Fig. 1 and 2. The fluorescence intensity
of cells with equal SCM values varied
up to threefold. Repeat measurements
of SCM values on the same cell differed
by less than 2%. The mean SCM values,
P, and fractions of lymphocyte popula-
tions, F, which respond with changes in
the SCM to stimulations with PHA and
CaBP are summarized in Table I. It
can be seen that in the 5 healthy donors
studied 45 to 5400 of the lymphocyte
population responds with a decrease in
the SCM to PHA stimulation and only
between 3 to 50 respond to CaBP
stimulation. In the 7 cancer patients
studied 36 to 4500 of the lymphocyte
population responded with a decrease in
the SCM to CaBP stimulation and 15 to
23% to PHA stimulation.
Examples of the distributions of SCM
values after stimulation with PHA and
CaBP in lymphocytes from a healthy
donor are shown in Fig. 1 and in those
from a cancer patient in Fig. 2. The
SCM values of stimulated lymphocytes
range from P = 0-08 to P- 0240.
DISCUSSION
The present study shows that changes
in the SCM can be measured on single
cells using a microscope fluorometer under
polarized light. The summary of the
results on mean values of the SCM
(P in Table I) corroborates our previous
findings on lymphocyte suspensions, mea-
sured in a fluorescence spectrophotometer,
that changes in SCM induced by PHA
and CaBP stimulation can be used to
differentiate between lymphocytes from
healthy donors and those from donors
with malignant disease (Cercek and Cer-
cek, 1975a; Cercek et al., 1974a). The
SCM values of individual lymphocytes in
populations of unstimulated lymphocytes
from healthy donors and from patients
with cancer range from P 0aIO to
P 0 30 (Fig. 1 and 2), with mean
values of P between 0.188 and 0-221
(Table I). This is in agreement with
measurements on unstimulated lympho-
TABLE I.-Mean SCM Values, P, and Fractions, F, ofLymphocyte Populations
Responding to PHA and CaBP Stimulation
Diagnosis
Healthy
Carcinoma of: epiglottis
alveolus
lung
larynx
tongue
lung
lower lip
Standard errors of P values are < ± 0. 003.
Age and
sex
22 M
21 M
28 M
46 M
45 F
63 M
52 M
54 M
62 M
83 F
50 M
64 M
Pcontrol
0-221
0 -220
0 205
0 215
0 200
0-188
0 210
0 202
0 203
0-201
0 -214
0 206
PPHA
0-150
0-149
0-154
0-158
0 155
0 185
0 205
0 200
0-196
0-198
0-216
0-201
FPHA
0-54
0 53
0-51
0 48
0 45
0-15
0-19
0 23
0-17
0-16
0 20
0 -21
PCaBP
0 - 212
0 - 214
0 200
0 206
0-192
0-149
0-155
0-158
0-160
0-155
0-178
0-147
FCaBP
0 04
0 05
0 03
0 04
0 05
0 36
0 45
0 39
0 40
0 42
0 43
0 42
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FIG. 1. Distribution of SCM values in a
population of lymphocytes from a healthy
donor before and after stimulation with
PHA and CaBP.
cyte suspensions carried out in a fluo-
rescence spectrophotometer which also
showed that there are no differences
between the unstimulated SCM values
of healthy donors and patients with
cancer (Cercek et al., 1974a). Furthers
more, the mean values of SCM derived
from single cell measurements (Table I)
confirm that lymphocytes from cancer
patients respond to stimulation by CaBP
with a decrease in the SCM, but not to
that by PHA, whereas lymphocytes from
healthy donors respond to stimulation by
PHA but not to that by CaBP. The
population distribution of P values in
stimulated lymphocytes is shifted to
lower SCM values (Fig. 1 and 2). Since
basic values of the SCM and responses
to stimulations are not age-dependent
to
C.
Uc
POLARIZATION. P
FIG. 2.-Distribution of SCM values in a
population of lymphocytes from a donor
with cancer before and after stimulation
with PHA and CaBP.
(loc. cit.), in this study cancer patients
and healthy donors are not age matched.
From the magnitude, mode and time
dependence of the SCM response of
lymphocytes to PHA and CaBP as
measured on cell suspensions, we inferred
that the same size and type ofthe popula-
tion (T-cells?) may be involved (loc.
cit.). The results in Table I show that
indeed large fractions of lymphocyte
populations respond to both PHA and
CaBP. In healthy donors at least 45
to 54% of the lymphocyte population
decreases the SCM on PHA stimulation,
and in cancer patients at least 36 to 45%
of the lymphocyte population responds
to CaBP stimulation. Our previous re-
sults on lymphocyte suspensions using
the fluorescence spectrophotometer tech-
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nique suggested that cancer patients'
lymphocytes do not change the mean
SCM on PHA stimulation and similarly
those from healthy donors do not on
CaBP stimulation. The mean values of
SCM (P in Table I) lead to the same
conclusion. However, the estimates of
F indicate that in healthy donors 3 to
5%0 ofthe lymphocyte population changes
its SCM on CaBP stimulation and that
in cancer patients 15 to 23% of the cell
population responds to PHA. The mag-
nitude of response of the responding
fractions could, however, be relatively
slight.
Figs. 1 and 2 provide no evidence
of bimodality in the value of P in stimu-
lated lymphocytes. They do not there-
fore support the idea that the lymphocytes
fall into two classes, responders and
non-responders, in spite of our large
estimates of F, " the responding frac-
tion ".
It must be stressed that these esti-
mates of F are minimal and are even
compatible with a uniform shift down-
wards in the P values of all the lympho-
cytes.
The magnitude of the responses of
single cells to stimulations by PHA and
CaBP cannot be derived from the present
results. To elucidate these points, further
studies on SCM charrges of single lympho-
cytes are in progress.
In conclusion, this study has demon-
strated the feasibility of SCM measure-
ments on single cells. It offers not only
an alternative to measurements of the
SCM on cell suspensions in a fluorescence
spectrophotometer (Cercek et al., 1973;
1974a, b), but also information on the
SCM distributions in cell populations and
changes in the SCM within the population
on stimulation or treatment with different
agents.
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